These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
257 related articles for article (PubMed ID: 30237424)
1. Bi-directional genetic modulation of GSK-3β exacerbates hippocampal neuropathology in experimental status epilepticus. Engel T; Gómez-Sintes R; Alves M; Jimenez-Mateos EM; Fernández-Nogales M; Sanz-Rodriguez A; Morgan J; Beamer E; Rodríguez-Matellán A; Dunleavy M; Sano T; Avila J; Medina M; Hernandez F; Lucas JJ; Henshall DC Cell Death Dis; 2018 Sep; 9(10):969. PubMed ID: 30237424 [TBL] [Abstract][Full Text] [Related]
2. GSK-3β-induced Tau pathology drives hippocampal neuronal cell death in Huntington's disease: involvement of astrocyte-neuron interactions. L'Episcopo F; Drouin-Ouellet J; Tirolo C; Pulvirenti A; Giugno R; Testa N; Caniglia S; Serapide MF; Cisbani G; Barker RA; Cicchetti F; Marchetti B Cell Death Dis; 2016 Apr; 7(4):e2206. PubMed ID: 27124580 [TBL] [Abstract][Full Text] [Related]
3. Spatiotemporal progression of ubiquitin-proteasome system inhibition after status epilepticus suggests protective adaptation against hippocampal injury. Engel T; Martinez-Villarreal J; Henke C; Jimenez-Mateos EM; Sanz-Rodriguez A; Alves M; Hernandez-Santana Y; Brennan GP; Kenny A; Campbell A; Lucas JJ; Henshall DC Mol Neurodegener; 2017 Feb; 12(1):21. PubMed ID: 28235423 [TBL] [Abstract][Full Text] [Related]
4. Lovastatin modulates glycogen synthase kinase-3β pathway and inhibits mossy fiber sprouting after pilocarpine-induced status epilepticus. Lee CY; Jaw T; Tseng HC; Chen IC; Liou HH PLoS One; 2012; 7(6):e38789. PubMed ID: 22761705 [TBL] [Abstract][Full Text] [Related]
5. Bi-lateral changes to hippocampal cholesterol levels during epileptogenesis and in chronic epilepsy following focal-onset status epilepticus in mice. Heverin M; Engel T; Meaney S; Jimenez-Mateos EM; Al-Saudi R; Henshall DC Brain Res; 2012 Oct; 1480():81-90. PubMed ID: 22921849 [TBL] [Abstract][Full Text] [Related]
6. Hippocampal damage after intra-amygdala kainic acid-induced status epilepticus and seizure preconditioning-mediated neuroprotection in SJL mice. Tanaka K; Jimenez-Mateos EM; Matsushima S; Taki W; Henshall DC Epilepsy Res; 2010 Feb; 88(2-3):151-61. PubMed ID: 19931419 [TBL] [Abstract][Full Text] [Related]
7. Antidepressant effects of creatine on amyloid β Rosa JM; Pazini FL; Cunha MP; Colla ARS; Manosso LM; Mancini G; Souza ACG; de Bem AF; Prediger RD; Rodrigues ALS Prog Neuropsychopharmacol Biol Psychiatry; 2018 Aug; 86():270-278. PubMed ID: 29753049 [TBL] [Abstract][Full Text] [Related]
8. Inactivation of glycogen synthase kinase-3beta protects against kainic acid-induced neurotoxicity in vivo. Goodenough S; Conrad S; Skutella T; Behl C Brain Res; 2004 Nov; 1026(1):116-25. PubMed ID: 15476703 [TBL] [Abstract][Full Text] [Related]
9. Prenatal Alcohol Exposure Leads to Enhanced Serine 9 Phosphorylation of Glycogen Synthase Kinase-3β (GSK-3β) in the Hippocampal Dentate Gyrus of Adult Mouse. Cunningham LA; Newville J; Li L; Tapia P; Allan AM; Valenzuela CF Alcohol Clin Exp Res; 2017 Nov; 41(11):1907-1916. PubMed ID: 28865114 [TBL] [Abstract][Full Text] [Related]
11. Safranal alleviates pentetrazole-induced epileptic seizures in mice by inhibiting the NF-κB signaling pathway and mitochondrial-dependent apoptosis through GSK-3β inactivation. Yan J; Li T; Ji K; Zhou X; Yao W; Zhou L; Huang P; Zhong K J Ethnopharmacol; 2024 Oct; 333():118408. PubMed ID: 38823659 [TBL] [Abstract][Full Text] [Related]
12. High concordance between hippocampal transcriptome of the mouse intra-amygdala kainic acid model and human temporal lobe epilepsy. Conte G; Parras A; Alves M; Ollà I; De Diego-Garcia L; Beamer E; Alalqam R; Ocampo A; Mendez R; Henshall DC; Lucas JJ; Engel T Epilepsia; 2020 Dec; 61(12):2795-2810. PubMed ID: 33070315 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of Wnt/β-catenin signaling and its modulators in repeated dose lithium-pilocarpine rat model of status epilepticus: An acute phase study. Gautam V; Rawat K; Sandhu A; Medhi B; Bhatia A; Kharbanda PS; Saha L Eur J Pharmacol; 2024 Mar; 966():176375. PubMed ID: 38307381 [TBL] [Abstract][Full Text] [Related]
14. RNA Interference Silencing of Glycogen Synthase Kinase 3β Inhibites Tau Phosphorylation in Mice with Alzheimer Disease. Bian H; Bian W; Lin X; Ma Z; Chen W; Pu Y Neurochem Res; 2016 Sep; 41(9):2470-80. PubMed ID: 27255602 [TBL] [Abstract][Full Text] [Related]
15. Intermittent fasting promotes adult hippocampal neuronal differentiation by activating GSK-3β in 3xTg-AD mice. Li W; Wu M; Zhang Y; Wei X; Zang J; Liu Y; Wang Y; Gong CX; Wei W J Neurochem; 2020 Dec; 155(6):697-713. PubMed ID: 32578216 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of glycogen synthase kinase 3 beta attenuates neurocognitive dysfunction resulting from cranial irradiation. Thotala DK; Hallahan DE; Yazlovitskaya EM Cancer Res; 2008 Jul; 68(14):5859-68. PubMed ID: 18632640 [TBL] [Abstract][Full Text] [Related]
17. Control of neuronal excitability by GSK-3beta: Epilepsy and beyond. Jaworski T Biochim Biophys Acta Mol Cell Res; 2020 Sep; 1867(9):118745. PubMed ID: 32450268 [TBL] [Abstract][Full Text] [Related]
18. Dysregulation of miRNAs Levels in Glycogen Synthase Kinase-3β Overexpressing Mice and the Role of miR-221-5p in Synaptic Function. Banach E; Szczepankiewicz A; Kaczmarek L; Jaworski T; Urban-Ciećko J Neuroscience; 2022 May; 490():287-295. PubMed ID: 35331845 [TBL] [Abstract][Full Text] [Related]
19. Efficacy of glycogen synthase kinase-3β targeting against osteosarcoma via activation of β-catenin. Shimozaki S; Yamamoto N; Domoto T; Nishida H; Hayashi K; Kimura H; Takeuchi A; Miwa S; Igarashi K; Kato T; Aoki Y; Higuchi T; Hirose M; Hoffman RM; Minamoto T; Tsuchiya H Oncotarget; 2016 Nov; 7(47):77038-77051. PubMed ID: 27780915 [TBL] [Abstract][Full Text] [Related]